Belgium-based UCB to acquire Neurona Therapeutics in a deal worth up to $1.15 billion

Belgian biopharmaceutical group UCB said on Friday it will acquire U.S.-based Neurona Therapeutics for up to $1.15 billion in a deal aimed …

Alamar Biosciences hits $1.5 billion valuation as shares surge in Nasdaq debut

Alamar Biosciences reached a $1.53 billion valuation after its protein biomarker detection platform saw shares surge 33% in its Nasdaq debut on …

Acanthamoeba Infection: Causes, Symptoms, Treatment and Prevention Guide

Acanthamoeba infection is a rare but serious condition caused by a group of microscopic, free-living amoebae commonly found in the environment. These …

Kennedy highlights food policy reforms but sidesteps vaccine issues in US Congress remarks

U.S. Health Secretary Robert F. Kennedy Jr. focused on nutrition and food safety in his remarks before lawmakers on Thursday, but largely …

Hims gains as FDA weighs wider peptide access, with analysts viewing it as a long-term positive

Shares of Hims & Hers Health rose more than 7% on Thursday after analysts said the U.S. drug regulator’s consideration of allowing …

OpenAI unveils GPT-Rosalind AI model for life sciences research

OpenAI on Thursday unveiled a new artificial intelligence model highlighting enhanced capabilities in biology and scientific research, as the company expands further …